PUBLISHER: The Business Research Company | PRODUCT CODE: 1938709
PUBLISHER: The Business Research Company | PRODUCT CODE: 1938709
Veterinary antimicrobial susceptibility testing serves as a crucial tool for veterinarians to select the most effective drugs for treating bacterial infections in animals. It aids in providing a comprehensive treatment history, encompassing prior antibiotic usage and relevant clinical background that could impact the animal's typical bacterial flora.
The primary product categories within veterinary antimicrobial susceptibility testing comprise disks and plates, culture media, accessories and consumables, and automated AST (antimicrobial susceptibility test) instruments. Disks and plates, small circular filter paper pieces soaked in antibiotic solutions and dried, are utilized to determine the antibiotics to which an infectious organism is susceptible. This information allows healthcare professionals to administer the appropriate medication. This testing is conducted on both livestock and companion animals, carried out in veterinary reference laboratories, veterinary research institutes, and other related facilities.
Tariffs have influenced the veterinary antimicrobial susceptibility testing market by increasing the cost of imported laboratory equipment, culture media, and consumables. This has primarily affected automated AST instruments and accessories in regions such as north america and europe, where imports form a significant portion of supply. Some positive impacts include encouraging local manufacturing and fostering innovation in cost-effective alternatives, which may strengthen domestic production and reduce dependency on global supply chains.
The veterinary antimicrobial susceptibility testing market research report is one of a series of new reports from The Business Research Company that provides veterinary antimicrobial susceptibility testing market statistics, including veterinary antimicrobial susceptibility testing industry global market size, regional shares, competitors with a veterinary antimicrobial susceptibility testing market share, detailed veterinary antimicrobial susceptibility testing market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary antimicrobial susceptibility testing industry. This veterinary antimicrobial susceptibility testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The veterinary antimicrobial susceptibility testing market size has grown strongly in recent years. It will grow from $39.63 billion in 2025 to $42.73 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to establishment of veterinary diagnostic labs, rising prevalence of bacterial infections in livestock, limited awareness of antimicrobial resistance, traditional culture-based testing methods, government regulations supporting animal health.
The veterinary antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $57.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to advancement in automated ast technologies, increasing adoption of precision medicine in veterinary care, growing companion animal population, rising investments in veterinary research, integration of cloud-based diagnostic data management. Major trends in the forecast period include rapid adoption of automated ast instruments, increasing demand for companion animal healthcare, growing awareness of antimicrobial resistance, expansion of veterinary reference laboratories, integration of advanced diagnostic workflows.
The rise in pet ownership is expected to drive growth in the veterinary antimicrobial susceptibility testing market in the coming years. Pet ownership refers to having and caring for a domesticated animal as a companion or family member. The increase in pet ownership is fueled by the desire for emotional companionship, with more households adopting pets for stress relief and improved mental well-being. Veterinary antimicrobial susceptibility testing supports pet health by ensuring effective treatment of infections, reducing illness duration, and maintaining overall well-being. For example, in 2023, according to Shelter Animals Count, a US-based non-governmental organization, 4.8 million animals in shelters and rescues were adopted into loving homes. Therefore, increasing pet ownership is driving the veterinary antimicrobial susceptibility testing market.
Leading players in the veterinary antimicrobial susceptibility testing market are introducing innovative products, such as rapid tests, to maintain their market position. Rapid tests, also called rapid diagnostic tests (RDTs) or rapid assays, are designed to provide results within a short time. For instance, in March 2023, PDX Biotech LLC, a US-based biotechnology company, launched the OraStripdx, a rapid test that detects active periodontal disease in dogs and cats within 10 seconds. The OraStripdx uses an easy-to-use test strip that changes color based on thiol concentrations in oral fluid, requiring no anesthesia or sedation. It can detect disease development in areas that are not directly visible, enabling pet owners and veterinary professionals to identify conditions at the earliest stages-a significant advantage.
In September 2023, Mars Incorporated, a US-based diversified manufacturing and pet health company, acquired SYNLAB Vet for an undisclosed amount. Through this acquisition, Mars aimed to expand its veterinary diagnostics and technology capabilities across Europe and strengthen its pet healthcare solutions within the Mars Petcare Science & Diagnostics division. SYNLAB Vet is a Germany-based veterinary diagnostics company specializing in providing laboratory diagnostic services and related technology solutions to veterinary professionals.
Major companies operating in the veterinary antimicrobial susceptibility testing market are BioMerieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Bruker Corporation, Condalab SA, FASTinov SA, Hardy Diagnostics Co., HiMedia Laboratories, Liofilchem Srl, Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synbiosis, Thermo Fisher Scientific Inc., Accelerate Diagnostics Inc., Alifax S.r.l., Biogal Galed Labs Ltd., Creative Diagnostics, Danaher Corporation, Eurofins Scientific SE, IDEXX Laboratories Inc., Merck Co. & KGaA, Microbiologics Inc., QIAGEN N.V., R-Biopharm AG, T2 Biosystems Inc., Vetoquinol S.A., Virbac Inc., Zoetis Inc.
North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2025. The regions covered in the veterinary antimicrobial susceptibility testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the veterinary antimicrobial susceptibility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The veterinary antimicrobial susceptibility testing market consists of revenues earned by entities by providing the disk diffusion technique and the broth dilution technique. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Antimicrobial Susceptibility Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses veterinary antimicrobial susceptibility testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for veterinary antimicrobial susceptibility testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary antimicrobial susceptibility testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.